neomento GmbH is a spin-off of DZNE, founded in 2020 and was previously funded by an EXIST “Transfer of Research” grant. The neomento team has developed VR- software that virtually maps traditional confrontation therapy in the treatment of anxiety disorders. The VR- software enables the use with patients with behavioral disorders as well as the training of everyday & social skills with maximum time flexibility.
immunX is an innovative platform using an ex-vivo human peripheral blood mononuclear cell (PBMC) assay combined with automation, imaging and computational methods to systemically profile the human innate immune system at basal level and in response to different stimuli. The platform allows phenotypic profiling /de-risking of test substances (e.g. drugs), PBMC stratification and is intended to facilitate the development of new medications and treatments.